BioLineRx Ltd. Amortisation Expense
BioLineRx Ltd. (BLRX) reported Amortisation Expense of $0 for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:AmortisationExpense · last filed 2026-03-23
- BioLineRx Ltd. amortisation expense for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- BioLineRx Ltd. amortisation expense for the quarter ending 2024-06-30 was $482.00K.
| Period end | Amortisation Expense 3 month | Amortisation Expense 6 month | Amortisation Expense 12 month |
|---|---|---|---|
| 2025-12-31 | $0.00 20-F · filed 2026-03-23 | ||
| 2025-06-30 | $0.00 6-K · filed 2025-08-14 | $0.00 6-K · filed 2025-08-14 | |
| 2024-12-31 | $3.32M 20-F · filed 2026-03-23 | ||
| 2024-06-30 | $482.00K 6-K · filed 2025-08-14 | $1.13M 6-K · filed 2025-08-14 | |
| 2023-12-31 | $450.00K 20-F · filed 2026-03-23 |